Beyond the Hype: The Scientific and Commercial Future of Microbiome Medicine

By aligning innovative scientific insights with strategic commercial pathways, the industry has the potential to fulfill its early promise – delivering safe, effective therapies that improve patient outcomes and create new opportunities for growth in the biopharmaceutical sector. The post Beyond the Hype: The Scientific and Commercial Future of Microbiome Medicine appeared first on MedCity…

Read More

State-Level Context for Federal Medicaid Cuts of $625 Billion and Enrollment Declines of 10.3 Million

Based on draft reconciliation language from the Energy & Commerce Committee, the Congressional Budget Office (CBO) released preliminary estimates showing proposed Medicaid changes would reduce federal Medicaid spending by $625 billion. Building on earlier KFF analysis, this analysis puts this magnitude of federal funding cuts into context by showing how the cuts relate to states’…

Read More

Novo Nordisk Turns to Self-Replicating RNA Startup to Discover New Metabolic Medicines

Obesity and type 2 diabetes are among the cardiometabolic diseases included in Novo Nordisk’s R&D pact with Replicate Biosciences, a deal that could pay out up to $550 million. Startup Replicate specializes in therapies and vaccines based on self-replicating RNA. The post Novo Nordisk Turns to Self-Replicating RNA Startup to Discover New Metabolic Medicines appeared…

Read More

Hospitals Leaders Share How They’re Balancing Finance, Innovation and Patient Care

During a recent panel, hospital leaders discussed how they approach the balancing act between innovation and financial sustainability. They shared tactics such as reassessing vendor contracts, leaning into existing tech capabilities and finding creative ways to support patients without compromising margins. The post Hospitals Leaders Share How They’re Balancing Finance, Innovation and Patient Care appeared…

Read More

What RFK Jr. Might Face in His Nomination Hearings This Week

President Donald Trump has nominated Robert F. Kennedy Jr., an environmental lawyer with no formal medical or public health expertise, as secretary of Health and Human Sciences. Two Senate committees will question Kennedy this week on how his disproven views of science and medicine qualify him to run the $1.7 trillion, 80,000-employee federal health system….

Read More

Compass Group and Crothall Healthcare Represented at 2025 Schneider Electric Paris Marathon

This year, Compass Group and Crothall Healthcare proudly reached the global stage at the 2025 Schneider Electric Paris Marathon through Pierre-Louis Ledent, who represented our organizations while supporting our valued partner and client, Team Allied Services.  “Running for a cause gives a much deeper meaning to performance,” Pierre-Louis explained. “As someone living with a chronic…

Read More